Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiongbin Lu

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Nature Nanotechnology|February 27, 2019
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 10, 2026
Nanoadjuvant-Mediated Electro-Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer TreatmentChengyue Zhang, Baohua Wang, Yacong Wang, et al.
Molecular Oncology|October 23, 2013
miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinaseYunfei Zhou, Guohui Wan, Riccardo Spizzo, et al.
Nature Nanotechnology|March 7, 2019
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Hepatology (Baltimore, Md.)|April 4, 2021
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under HypoxiaYi Niu, Ziyou Lin, Arabella Wan, et al.
Nature Communications|February 10, 2018
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistanceHai Wang, Zan Gao, Xuanyou Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2020
Bioinspired One Cell Culture Isolates Highly Tumorigenic and Metastatic Cancer Stem Cells Capable of Multilineage DifferentiationHai Wang, Pranay Agarwal, Bin Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2023
A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer ImmunotherapyZhuolong Zhou, Kevin Van der Jeught, Yujing Li, et al.
Acta Pharmaceutica Sinica. B|January 23, 2024
A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistanceLei Sun, Arabella H Wan, Shijia Yan, et al.
Molecular Cancer Research : MCR|June 5, 2015
VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer CellsXiangcang Ye, Fan Fan, Rajat Bhattacharya, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Nature Nanotechnology|February 27, 2019
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 10, 2026
Nanoadjuvant-Mediated Electro-Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer TreatmentChengyue Zhang, Baohua Wang, Yacong Wang, et al.
Molecular Oncology|October 23, 2013
miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinaseYunfei Zhou, Guohui Wan, Riccardo Spizzo, et al.
Nature Nanotechnology|March 7, 2019
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancerJiangsheng Xu, Yunhua Liu, Yujing Li, et al.
Hepatology (Baltimore, Md.)|April 4, 2021
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under HypoxiaYi Niu, Ziyou Lin, Arabella Wan, et al.
Nature Communications|February 10, 2018
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistanceHai Wang, Zan Gao, Xuanyou Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2020
Bioinspired One Cell Culture Isolates Highly Tumorigenic and Metastatic Cancer Stem Cells Capable of Multilineage DifferentiationHai Wang, Pranay Agarwal, Bin Jiang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 5, 2023
A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer ImmunotherapyZhuolong Zhou, Kevin Van der Jeught, Yujing Li, et al.
Acta Pharmaceutica Sinica. B|January 23, 2024
A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistanceLei Sun, Arabella H Wan, Shijia Yan, et al.
Molecular Cancer Research : MCR|June 5, 2015
VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer CellsXiangcang Ye, Fan Fan, Rajat Bhattacharya, et al.
Pageof 12